Texas was often viewed as one of the most restrictive states in terms of medical cannabis, especially in 2015 when it approved the Compassionate Use Program, which covered only one condition – intractable epilepsy – and allowed patients to consume only “low-THC” products (from 0.3% to 0.5% THC) while denying access to smokable cannabis flower and forbidding home cultivation.
Since then, things have changed. Limitations are slowly being removed and new cannabis regulations are under consideration. Just this week, several cannabis-related measures were approved in the House, including a proposal to research the potential of psychedelics such as psilocybin and MDMA and to expand the state’s medical cannabis program by adding more qualifying conditions to the list, reported Marijuana Moment.
Under this bill, approved on Wednesday, the Department of State Health Services would add cancer, chronic pain and post-traumatic stress disorder (PTSD) to its list of qualifying conditions. It could also raise the THC cap for medical cannabis products from 0.5% to 5%.
– Read the entire article at Benzinga.